...
首页> 外文期刊>The Journal of Nuclear Medicine >Prognostic Value of Myocardial Salvage Achieved by Reperfusion Therapy in Patients with Acute Myocardial Infarction
【24h】

Prognostic Value of Myocardial Salvage Achieved by Reperfusion Therapy in Patients with Acute Myocardial Infarction

机译:再灌注疗法对急性心肌梗死患者挽救心肌的预后价值

获取原文
   

获取外文期刊封面封底 >>

       

摘要

id="p-1">Myocardial salvage assessed by 99mTc-sestamibi scintigraphy is a marker of myocardial tissue reperfusion in patients with acute myocardial infarction. The prognostic value of myocardial salvage index in patients with acute myocardial infarction after reperfusion therapy has not, however, been investigated. >Methods: We analyzed 765 patients with acute myocardial infarction randomized to treatment by coronary stenting (383 patients), primary coronary angioplasty (251 patients), or thrombolysis (131 patients) in the setting of 3 randomized trials. Initial (before reperfusion therapy) and follow-up (7-14 d after reperfusion therapy) scintigraphic examinations were performed to assess the initial perfusion defect, final infarct size, and salvage index. Patients were categorized into 2 groups defined by the median salvage index (0.5): the group with salvage index 0.5 (374 patients) and the group with salvage index a‰¥ 0.5 (391 patients). The primary endpoint of the study was mortality at 6 mo after the index event. >Results: Six-month mortality was 5.1% (19 deaths) in the group with salvage index 0.5, compared with 1.0% (4 deaths) in the group with salvage index a‰¥ 0.5 (odds ratio, 5.1; 95% confidence interval, 1.9-13.3; P = 0.001). Salvage index (median [25th, 75th percentiles] was significantly smaller in nonsurvivors than in survivors (0.19 [0.05, 0.37] vs. 0.50 [0.26, 0.80], P = 0.0004). The Cox proportional hazards model showed that myocardial salvage index (P = 0.0007), initial perfusion defect (P = 0.0007), and age (P = 0.04) were independently associated with 6-mo mortality. >Conclusion: Myocardial salvage achieved by reperfusion therapy predicts mortality in patients with acute myocardial infarction. Our findings support the use of salvage index as a surrogate of mortality in clinical trials designed to test the efficacy of reperfusion therapies among patients with acute myocardial infarction.
机译:99m Tc-sestamibi闪烁显像法评估的心肌抢救是急性心肌梗死患者心肌组织再灌注的标志。但是,尚未研究再灌注治疗后急性心肌梗死患者心肌挽救指数的预后价值。 >方法:在3项随机试验中,我们分析了765例急性心肌梗塞患者,这些患者随机接受冠状动脉支架置入术(383例),原发性冠状动脉成形术(251例)或溶栓(131例)。进行了初始(再灌注治疗前)和随访(再灌注治疗后7-14 d)闪烁显像检查,以评估初始灌注缺陷,最终梗死面积和挽救指数。按中位挽救指数(0.5)将患者分为两组:挽救指数<0.5的组(374例)和挽救指数≥0.5的组(391例)。该研究的主要终点是指标事件发生后6个月的死亡率。 >结果:挽救指数<0.5的组的六个月死亡率为5.1%(19例死亡),而挽救指数为a ¥ 0.5的组的六个月死亡率为1.0%(4例死亡)(赔率) ,5.1; 95%置信区间1.9-13.3; P = 0.001)。救助指数(中位[25%,75%]在非幸存者中明显小于幸存者(0.19 [0.05,0.37]对0.50 [0.26,0.80], P = 0.0004)。Cox比例风险模型显示心肌抢救指数( P = 0.0007),初始灌注缺陷( P = 0.0007)和年龄( P = 0.04) >结论:通过再灌注疗法获得的心肌挽救可预测急性心肌梗死患者的死亡率,我们的研究结果支持在临床试验中使用挽救指数作为死亡率的替代指标在急性心肌梗死患者中测试再灌注疗法的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号